The John C Martin Centre for Liver Research and Innovations, named after the late philanthropist, will focus on non-alcoholic ...

David Bonderman, the colorful yet publicity-shy co-founder of Fort Worth-based private equity titan TPG Inc. who became a billionaire by spearheading ...

Shares of Gilead Sciences Inc. GILD inched 0.04% higher to $92.38 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.82% to 6 ...

David Bonderman, the colorful yet publicity-shy co-founder of private equity titan TPG who became a billionaire by spearheading massive company takeovers, bailouts of foundering enterprises and ...

The drug has been shown to be effective at preventing HIV infection but does not cure an existing HIV infection.

GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.

Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.

Patients with germline BRCA mutations who were diagnosed with breast cancer at or before age 40 and who underwent a bilateral risk-reducing mastectomy (RRM) and/or a risk-reducing ...

Cardiff Oncology CRDF announced robust efficacy data from an ongoing mid-stage study evaluating two doses of its lead ...

Qure N.V. QURE surged 109.7% after it announced reaching alignment with the FDA on key elements of an accelerated approval ...

Pharma company Gilead Sciences has been awarded a massive $31.8 million in damages in connection with a lawsuit claiming ...

Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential ...